- Home
- WGRX vs RAND Comparison
WGRX vs RAND Comparison
Compare WGRX & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGRX
- RAND
- Stock Information
- Founded
- WGRX 2022
- RAND 1969
- Country
- WGRX United States
- RAND United States
- Employees
- WGRX N/A
- RAND N/A
- Industry
- WGRX Other Pharmaceuticals
- RAND Finance: Consumer Services
- Sector
- WGRX Health Care
- RAND Finance
- Exchange
- WGRX Nasdaq
- RAND Nasdaq
- Market Cap
- WGRX 54.8M
- RAND 44.7M
- IPO Year
- WGRX 2025
- RAND N/A
- Fundamental
- Price
- WGRX $0.58
- RAND N/A
- Analyst Decision
- WGRX
- RAND
- Analyst Count
- WGRX 0
- RAND 0
- Target Price
- WGRX N/A
- RAND N/A
- AVG Volume (30 Days)
- WGRX 1.2M
- RAND 4.0K
- Earning Date
- WGRX 11-11-2025
- RAND 11-05-2025
- Dividend Yield
- WGRX N/A
- RAND 11.86%
- EPS Growth
- WGRX N/A
- RAND N/A
- EPS
- WGRX N/A
- RAND N/A
- Revenue
- WGRX $36,738,599.00
- RAND $7,966,118.00
- Revenue This Year
- WGRX N/A
- RAND N/A
- Revenue Next Year
- WGRX N/A
- RAND N/A
- P/E Ratio
- WGRX N/A
- RAND N/A
- Revenue Growth
- WGRX 82384.51
- RAND 1.16
- 52 Week Low
- WGRX $0.56
- RAND $13.82
- 52 Week High
- WGRX $7.04
- RAND $31.89
- Technical
- Relative Strength Index (RSI)
- WGRX 28.88
- RAND 39.99
- Support Level
- WGRX $0.57
- RAND $13.85
- Resistance Level
- WGRX $0.67
- RAND $14.49
- Average True Range (ATR)
- WGRX 0.10
- RAND 0.44
- MACD
- WGRX -0.03
- RAND -0.02
- Stochastic Oscillator
- WGRX 2.56
- RAND 17.16
About WGRX Wellgistics Health Inc. Common Stock
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.